Introduction/Purpose
Independent dosimetric audits for radiotherapy centers are internationally recommended to improve the treatment quality and safety for radiotherapy patients. The Australian Clinical Dosimetry Service, (ACDS), is a federally funded pilot dosimetry audit designed so that the Australian Government could determine whether the bespoke design was suitable for an on-going Australian service. The service requirements were defined by a memorandum of understanding (MoU) between the Australian Radiation Protection and Nuclear Safety Agency, (ARPANSA) and the Department of Health.
Aim
The ACDS audits are used to determine whether the dose being delivered to patients is the dose intended to be delivered to patients.
Method
Three main audits, Level I, II and III, each with increasing complexity are offered by the ACDS. In addition, a more precise on-site audit, which uses an ionisation chamber with the facility's water tank, is also offered. This Level Ib audit is used to resolve uncertainties arsing from the higher level audits, and is favoured for newly installed linacs prior to clinical release. A clinical advisory group, CAG, was recruited from the Australian professionals to advise and assist the ACDS audit designs, audit interpretations and clinical consequences from audit outcomes.
Results
Figure 1d: The Level III audit is an imaging-to-treatment audit, IAEA TECDOC 1583 [2] . A CIRS 002LFC IMRT Thorax Phantom is used 
